These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38063008)

  • 1. Virologic Nonsuppression and HIV Drug Resistance Among People Who Inject Drugs and Their Sexual and Injecting Partners in Kenya.
    Chohan BH; Kingston H; Tseng AS; Sambai B; Guthrie BL; Wilkinson E; Giandhari J; Mbogo LW; Monroe-Wise A; Masyuko S; Bosire R; Ludwig-Barron NT; Sinkele W; Bukusi D; de Oliveria T; Farquhar C; Herbeck JT
    AIDS Res Hum Retroviruses; 2024 May; 40(5):240-250. PubMed ID: 38063008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
    Segujja F; Omooja J; Lunkuse S; Nanyonjo M; Nabirye SE; Nassolo F; Bugembe DL; Bbosa N; Kateete DP; Ssenyonga W; Mayanja Y; Nsubuga RN; Seeley J; Kaleebu P; Ssemwanga D
    AIDS Res Hum Retroviruses; 2020 Sep; 36(9):782-791. PubMed ID: 32475121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study.
    Lippman SA; Mooney AC; Puren A; Hunt G; Grignon JS; Prach LM; Gilmore HJ; Truong HM; Barnhart S; Liegler T
    BMC Infect Dis; 2020 Mar; 20(1):248. PubMed ID: 32216752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of violence among sexual and injecting partners of people who inject drugs living with HIV in Kenya: a cross-sectional study.
    Aung SWKH; Kingston H; Mbogo LW; Sambai B; Monroe-Wise A; Ludwig-Barron NT; Bukusi D; Sinkele W; Gitau E; Masyuko S; Herbeck JT; Farquhar C; Guthrie BL
    Harm Reduct J; 2023 Nov; 20(1):164. PubMed ID: 37919736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients.
    Bossard C; Schramm B; Wanjala S; Jain L; Mucinya G; Opollo V; Wiesner L; van Cutsem G; Poulet E; Szumilin E; Ellman T; Maman D
    J Acquir Immune Defic Syndr; 2021 Jul; 87(3):883-888. PubMed ID: 33852504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
    Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
    PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.
    Chung MH; McGrath CJ; Beck IA; Levine M; Milne RS; So I; Andersen N; Dross S; Coombs RW; Chohan B; Yatich N; Kiptinness C; Sakr SR; Kiarie JN; Frenkel LM
    Lancet HIV; 2020 Feb; 7(2):e104-e112. PubMed ID: 31818716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.
    Small W; Milloy MJ; McNeil R; Maher L; Kerr T
    AIDS Res Ther; 2016; 13():26. PubMed ID: 27462360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis.
    Mumtaz GR; Awad SF; Feizzadeh A; Weiss HA; Abu-Raddad LJ
    J Int AIDS Soc; 2018 Mar; 21(3):e25102. PubMed ID: 29577623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya: A cross-sectional study.
    Scriven YA; Mulinge MM; Saleri N; Luvai EA; Nyachieo A; Maina EN; Mwau M
    Medicine (Baltimore); 2021 Oct; 100(40):e27460. PubMed ID: 34622871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
    Lesko CR; Tong W; Moore RD; Lau B
    AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi.
    Neuhann F; de Forest A; Heger E; Nhlema A; Scheller C; Kaiser R; Steffen HM; Tweya H; Fätkenheuer G; Phiri S
    AIDS Res Ther; 2020 May; 17(1):22. PubMed ID: 32434561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya.
    Makwaga O; Adhiambo M; Mulama DH; Muoma J; Adungo F; Wanjiku H; Ongaya A; Maitha GM; Mwau M
    Pan Afr Med J; 2020; 37():311. PubMed ID: 33654530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment.
    Chohan BH; Ronen K; Khasimwa B; Matemo D; Osborn L; Unger JA; Drake AL; Beck IA; Frenkel LM; Kinuthia J; John-Stewart G
    PLoS One; 2021; 16(8):e0256249. PubMed ID: 34407133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Level of HIV Drug Resistance and Virologic Nonsuppression Among Female Sex Workers in Ethiopia: A Nationwide Cross-Sectional Study.
    Arimide DA; Amogne MD; Kebede Y; Balcha TT; Adugna F; Ramos A; DeVos J; Zeh C; Agardh A; Chih-Wei Chang J; Björkman P; Medstrand P
    J Acquir Immune Defic Syndr; 2022 Apr; 89(5):566-574. PubMed ID: 34966147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.
    Kityo C; Thompson J; Nankya I; Hoppe A; Ndashimye E; Warambwa C; Mambule I; van Oosterhout JJ; Wools-Kaloustian K; Bertagnolio S; Easterbrook PJ; Mugyenyi P; Walker AS; Paton NI;
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):e45-e54. PubMed ID: 28129253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral resistance among HIV-1 patients on first-line therapy attending a comprehensive care clinic in Kenyatta National Hospital, Kenya: a retrospective analysis.
    Kinyua JG; Lihana RW; Kiptoo M; Muasya T; Odera I; Muiruri P; Songok EM
    Pan Afr Med J; 2018; 29():186. PubMed ID: 30061964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.